Table 3.
Studies on Prevalence of Chagas Disease in Latin American-Born Populations in the United States (2010–2020)a
| Study | Population | Prevalence, % |
|---|---|---|
| Castro-Sesquen et al 2020 [13] | 1514 people in the greater Washington, DC metropolitan area (community screening program) | 3.8 |
| Hernandez et al 2019 [14] | 189 relatives of 86 previously diagnosed patients with Chagas Disease | 7.4 |
| Manne-Goehler et al 2019 [15] | 5125 people from endemic regions screened in primary care setting in East Boston | 1.0 |
| Meymandi et al 2017 [16] | 4755 Latin American-born residents of Los Angeles (community screening program) | 1.2 |
| Traina et al 2017 [17] | 327 hospital patients with electrocardiogram abnormalities | 5.2 |
| Park et al 2017 [18] | 80 patients with pacemakers | 7.5 |
| Traina et al 2015 [19] | 135 hospital patients with nonischemic cardiomyopathy | 19.0 |
| Kapelusznik et al 2013 [20] | 39 hospital patients with nonischemic cardiomyopathy | 13.0 |
All study populations consist of people who were born or lived a significant amount of time in endemic countries of Latin America.